Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

USA - NASDAQ:BLMN - US0942351083 - Common Stock

6.685 USD
-0.02 (-0.22%)
Last: 9/18/2025, 10:08:58 AM
Fundamental Rating

3

BLMN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of BLMN while its profitability can be described as average. BLMN is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BLMN was profitable.
In the past year BLMN had a positive cash flow from operations.
In multiple years BLMN reported negative net income over the last 5 years.
Each year in the past 5 years BLMN had a positive operating cash flow.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

With a Return On Assets value of -0.15%, BLMN is not doing good in the industry: 66.92% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -1.25%, BLMN is in line with its industry, outperforming 48.87% of the companies in the same industry.
With a Return On Invested Capital value of 4.48%, BLMN perfoms like the industry average, outperforming 45.11% of the companies in the same industry.
BLMN had an Average Return On Invested Capital over the past 3 years of 9.55%. This is significantly below the industry average of 15.68%.
The last Return On Invested Capital (4.48%) for BLMN is well below the 3 year average (9.55%), which needs to be investigated, but indicates that BLMN had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.15%
ROE -1.25%
ROIC 4.48%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

With a Operating Margin value of 3.89%, BLMN is not doing good in the industry: 67.67% of the companies in the same industry are doing better.
BLMN's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 71.11%, BLMN belongs to the best of the industry, outperforming 84.96% of the companies in the same industry.
BLMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.89%
PM (TTM) N/A
GM 71.11%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BLMN is still creating some value.
Compared to 1 year ago, BLMN has less shares outstanding
BLMN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BLMN is higher compared to a year ago.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.85, we must say that BLMN is in the distress zone and has some risk of bankruptcy.
BLMN has a worse Altman-Z score (0.85) than 70.68% of its industry peers.
BLMN has a debt to FCF ratio of 15.15. This is a negative value and a sign of low solvency as BLMN would need 15.15 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 15.15, BLMN is in line with its industry, outperforming 47.37% of the companies in the same industry.
BLMN has a Debt/Equity ratio of 2.34. This is a high value indicating a heavy dependency on external financing.
BLMN's Debt to Equity ratio of 2.34 is in line compared to the rest of the industry. BLMN outperforms 48.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 15.15
Altman-Z 0.85
ROIC/WACC0.5
WACC8.94%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

BLMN has a Current Ratio of 0.43. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
BLMN has a Current ratio of 0.43. This is amonst the worse of the industry: BLMN underperforms 81.95% of its industry peers.
A Quick Ratio of 0.35 indicates that BLMN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.35, BLMN is doing worse than 79.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.35
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

0

3. Growth

3.1 Past

BLMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.08%.
Measured over the past 5 years, BLMN shows a small growth in Earnings Per Share. The EPS has been growing by 3.30% on average per year.
BLMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.61%.
Measured over the past years, BLMN shows a decrease in Revenue. The Revenue has been decreasing by -0.93% on average per year.
EPS 1Y (TTM)-37.08%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-35.29%
Revenue 1Y (TTM)-19.61%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-10.41%

3.2 Future

Based on estimates for the next years, BLMN will show a decrease in Earnings Per Share. The EPS will decrease by -9.66% on average per year.
The Revenue is expected to decrease by -2.95% on average over the next years.
EPS Next Y-39.54%
EPS Next 2Y-19.55%
EPS Next 3Y-9.66%
EPS Next 5YN/A
Revenue Next Year-11.35%
Revenue Next 2Y-5.15%
Revenue Next 3Y-2.95%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.43 indicates a rather cheap valuation of BLMN.
Compared to the rest of the industry, the Price/Earnings ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 97.74% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, BLMN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 5.74, the valuation of BLMN can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 96.24% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BLMN to the average of the S&P500 Index (22.70), we can say BLMN is valued rather cheaply.
Industry RankSector Rank
PE 4.43
Fwd PE 5.74
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 93.23% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BLMN is valued cheaply inside the industry as 92.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.24
EV/EBITDA 4.7
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

BLMN's earnings are expected to decrease with -9.66% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.34
EPS Next 2Y-19.55%
EPS Next 3Y-9.66%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.67%, BLMN is a good candidate for dividend investing.
The stock price of BLMN dropped by -29.55% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.93, BLMN pays a better dividend. On top of this BLMN pays more dividend than 96.99% of the companies listed in the same industry.
BLMN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 8.67%

5.2 History

The dividend of BLMN is nicely growing with an annual growth rate of 19.12%!
BLMN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BLMN decreased in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years0
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of BLMN are negative and hence is the payout ratio. BLMN will probably not be able to sustain this dividend level.
DP-1330.72%
EPS Next 2Y-19.55%
EPS Next 3Y-9.66%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (9/18/2025, 10:08:58 AM)

6.685

-0.02 (-0.22%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners103.54%
Inst Owner Change2.48%
Ins Owners1.65%
Ins Owner Change3.44%
Market Cap568.69M
Analysts54.44
Price Target7.7 (15.18%)
Short Float %10.28%
Short Ratio3.3
Dividend
Industry RankSector Rank
Dividend Yield 8.67%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-1330.72%
Div Incr Years0
Div Non Decr Years2
Ex-Date08-19 2025-08-19 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.74%
Min EPS beat(2)3.69%
Max EPS beat(2)13.79%
EPS beat(4)4
Avg EPS beat(4)5.28%
Min EPS beat(4)0.68%
Max EPS beat(4)13.79%
EPS beat(8)6
Avg EPS beat(8)1.3%
EPS beat(12)10
Avg EPS beat(12)3.14%
EPS beat(16)13
Avg EPS beat(16)4%
Revenue beat(2)0
Avg Revenue beat(2)-0.19%
Min Revenue beat(2)-0.32%
Max Revenue beat(2)-0.06%
Revenue beat(4)0
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-2.28%
Max Revenue beat(4)-0.06%
Revenue beat(8)0
Avg Revenue beat(8)-1.59%
Revenue beat(12)1
Avg Revenue beat(12)-1.69%
Revenue beat(16)2
Avg Revenue beat(16)-1.69%
PT rev (1m)-18.02%
PT rev (3m)-14.21%
EPS NQ rev (1m)-61.42%
EPS NQ rev (3m)-299.03%
EPS NY rev (1m)-11.8%
EPS NY rev (3m)-13.06%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)0.75%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 4.43
Fwd PE 5.74
P/S 0.15
P/FCF 9.24
P/OCF 2.42
P/B 1.43
P/tB N/A
EV/EBITDA 4.7
EPS(TTM)1.51
EY22.59%
EPS(NY)1.16
Fwd EY17.43%
FCF(TTM)0.72
FCFY10.82%
OCF(TTM)2.76
OCFY41.33%
SpS43.36
BVpS4.67
TBVpS-3.12
PEG (NY)N/A
PEG (5Y)1.34
Profitability
Industry RankSector Rank
ROA -0.15%
ROE -1.25%
ROCE 5.66%
ROIC 4.48%
ROICexc 4.57%
ROICexgc 6.23%
OM 3.89%
PM (TTM) N/A
GM 71.11%
FCFM 1.67%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
ROICexc(3y)9.93%
ROICexc(5y)N/A
ROICexgc(3y)14.52%
ROICexgc(5y)N/A
ROCE(3y)12.09%
ROCE(5y)N/A
ROICexcg growth 3Y-22.65%
ROICexcg growth 5Y1.95%
ROICexc growth 3Y-20.61%
ROICexc growth 5Y2.37%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score6
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 15.15
Debt/EBITDA 3.01
Cap/Depr 104.97%
Cap/Sales 4.7%
Interest Coverage 2.42
Cash Conversion 76.16%
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.35
Altman-Z 0.85
F-Score6
WACC8.94%
ROIC/WACC0.5
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.08%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-35.29%
EPS Next Y-39.54%
EPS Next 2Y-19.55%
EPS Next 3Y-9.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.61%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-10.41%
Revenue Next Year-11.35%
Revenue Next 2Y-5.15%
Revenue Next 3Y-2.95%
Revenue Next 5YN/A
EBIT growth 1Y-52.2%
EBIT growth 3Y-18.98%
EBIT growth 5Y0.71%
EBIT Next Year32.57%
EBIT Next 3Y12.2%
EBIT Next 5YN/A
FCF growth 1Y-64.71%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-48.83%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%